Document is current
Any future updates will be listed below
-
Authors
Mamlins, Eduards
Novruzov, Emil https://orcid.org/0000-0003-1914-1332
Watabe, Tadashi
Mori, Yuriko
Dabir, Mardjan
Mattes-György, Katalin
Antke, Christina
Henke, Jan
Boschheidgen, Matthias
Kirchner, Julian
Jazmati, Danny
Hausmann, Jan
Radtke, Jan P.
Niegisch, Günter
Cardinale, Jens
Hörner-Rieber, Juliane
Albers, Peter
Antoch, Gerald
Giesel, Frederik L.
Schimmöller, Lars
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 26 February 2025
Accepted: 2 May 2025
First Online: 30 May 2025
Declarations
:
: All procedures performed in studies involving human participants were approved by the ethics committee and carried out in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study received approval from the Ethical Committee of the Medical Faculty of Heinrich-Heine University Duesseldorf, Germany (Study-Nr.: 2022–1898). Clinical trial number: not applicable.
: Informed consent for participation was obtained from all individual participants included in the study, and the investigation was conducted according to national regulatory laws.
: Not applicable.
: FLG has patent applications for [18F]PSMA-1007 and is an advisor at ABX, Telix, and SOFIE Biosciences. The authors have no relevant financial or nonfinancial interests to disclose.
